Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Hwang

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
Archives of Pathology & Laboratory Medicine|April 16, 2024
Programmed Death Ligand-1 and Tumor Mutation Burden Testing of Patients With Lung Cancer for Selection of Immune Checkpoint Inhibitor Therapies: Guideline From the College of American Pathologists, Association for Molecular Pathology, International Association for the Study of Lung Cancer, Pulmonary Pathology Society, and LUNGevity FoundationLynette M Sholl, Mark Awad, Upal Basu Roy, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 3, 2019
Mesenchymal stromal cell therapy during ex vivo lung perfusion ameliorates ischemia-reperfusion injury in lung transplantationDaisuke Nakajima, Yui Watanabe, Akihiro Ohsumi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 15, 2018
Translation of Knowledge to Practice-Improving Awareness in NSCLC Molecular TestingAlona Zer, Jean Claude Cutz, Harman Sekhon, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 3, 2009
Induction chemoradiotherapy facilitates radical resection of T4 non-small cell lung cancer invading the spineMasaki Anraku, Thomas K Waddell, Marc de Perrot, et al.
Cells|May 24, 2024
Lung Transplant Immunomodulation with Genetically Engineered Mesenchymal Stromal Cells-Therapeutic Window for Interleukin-10Antti I Nykänen, Andrea Mariscal, Allen Duong, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 20, 2021
CCTG BR34: A Randomized Phase 2 Trial of Durvalumab and Tremelimumab With or Without Platinum-Based Chemotherapy in Patients With Metastatic NSCLCNatasha B Leighl, Scott A Laurie, Glenwood D Goss, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 6, 2019
Localized malignant mesothelioma, an unusual and poorly characterized neoplasm of serosal origin: best current evidence from the literature and the International Mesothelioma PanelAlberto M Marchevsky, Andras Khoor, Ann E Walts, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 16, 2023
Canadian Multicentric Pan-TRK (CANTRK) Immunohistochemistry Harmonization StudyMartin D Hyrcza, Sebastiao N Martins-Filho, Alan Spatz, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 19, 2020
Canadian Multicenter Project on Standardization of Programmed Death-Ligand 1 Immunohistochemistry 22C3 Laboratory-Developed Tests for Pembrolizumab Therapy in NSCLCEmina Torlakovic, Roula Albadine, Gilbert Bigras, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 29, 2022
Prognostic implications of and clinical risk factors for acute lung injury and organizing pneumonia after lung transplantation: Data from a multicenter prospective cohort studyElizabeth N Pavlisko, Megan L Neely, Heather Kopetskie, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
Archives of Pathology & Laboratory Medicine|April 16, 2024
Programmed Death Ligand-1 and Tumor Mutation Burden Testing of Patients With Lung Cancer for Selection of Immune Checkpoint Inhibitor Therapies: Guideline From the College of American Pathologists, Association for Molecular Pathology, International Association for the Study of Lung Cancer, Pulmonary Pathology Society, and LUNGevity FoundationLynette M Sholl, Mark Awad, Upal Basu Roy, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 3, 2019
Mesenchymal stromal cell therapy during ex vivo lung perfusion ameliorates ischemia-reperfusion injury in lung transplantationDaisuke Nakajima, Yui Watanabe, Akihiro Ohsumi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 15, 2018
Translation of Knowledge to Practice-Improving Awareness in NSCLC Molecular TestingAlona Zer, Jean Claude Cutz, Harman Sekhon, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 3, 2009
Induction chemoradiotherapy facilitates radical resection of T4 non-small cell lung cancer invading the spineMasaki Anraku, Thomas K Waddell, Marc de Perrot, et al.
Cells|May 24, 2024
Lung Transplant Immunomodulation with Genetically Engineered Mesenchymal Stromal Cells-Therapeutic Window for Interleukin-10Antti I Nykänen, Andrea Mariscal, Allen Duong, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 20, 2021
CCTG BR34: A Randomized Phase 2 Trial of Durvalumab and Tremelimumab With or Without Platinum-Based Chemotherapy in Patients With Metastatic NSCLCNatasha B Leighl, Scott A Laurie, Glenwood D Goss, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 6, 2019
Localized malignant mesothelioma, an unusual and poorly characterized neoplasm of serosal origin: best current evidence from the literature and the International Mesothelioma PanelAlberto M Marchevsky, Andras Khoor, Ann E Walts, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 16, 2023
Canadian Multicentric Pan-TRK (CANTRK) Immunohistochemistry Harmonization StudyMartin D Hyrcza, Sebastiao N Martins-Filho, Alan Spatz, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 19, 2020
Canadian Multicenter Project on Standardization of Programmed Death-Ligand 1 Immunohistochemistry 22C3 Laboratory-Developed Tests for Pembrolizumab Therapy in NSCLCEmina Torlakovic, Roula Albadine, Gilbert Bigras, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 29, 2022
Prognostic implications of and clinical risk factors for acute lung injury and organizing pneumonia after lung transplantation: Data from a multicenter prospective cohort studyElizabeth N Pavlisko, Megan L Neely, Heather Kopetskie, et al.
Pageof 10